Success Story: Despite RFE! Our Firm Assisted a Bangladeshi Graduate Teaching Assistant Secure NIW Approval
Client’s Testimonial:
“I’m grateful to the law firm for taking my case and supporting me throughout the I-140 process. They responded promptly, provided clear answers with evidence, and acted quickly when I received an RFE. Thanks to their professionalism and dedication, my case was approved. Thank you to the entire team!”
On January 30th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Teaching Assistant in the Field of Pharmacology (Approval Notice).
General Field: Pharmacology
Position at the Time of Case Filing: Graduate Teaching Assistant
Country of Origin: Bangladesh
State of Residence at the Time of Filing: Wisconsin
Approval Notice Date: January 30th, 2025
Processing Time: 6 months, 27 days (Premium Processing Requested)
Case Summary:
NAILG is pleased to announce the approval of an EB-2 National Interest Waiver (NIW) petition for a pharmacology researcher advancing critical biomedical discoveries. At the time of filing, the client was pursuing her proposed endeavor of leveraging sophisticated biochemical techniques to investigate the interaction between LSD1 and RNA-DNA hybrids. Her research provides novel insights into how these molecular mechanisms influence gene expression and contribute to the pathology of Ewing sarcoma, a rare and aggressive childhood cancer. By advancing knowledge in this area, her work supports the development of targeted therapies with fewer side effects, directly addressing urgent needs in cancer treatment and public health.
Research with Substantial Merit and National Importance
We demonstrated that the client’s research is of both substantial merit and national importance. Ewing sarcoma presents significant clinical and socioeconomic challenges, with limited effective treatment options and high relapse rates. Her studies contribute to improving therapeutic strategies, reducing recurrence, and ultimately saving lives. Beyond individual health outcomes, this work alleviates the broader financial and social burden of cancer care in the United States. By tackling a disease with profound medical and economic implications, her research directly aligns with national priorities to strengthen healthcare innovation and patient outcomes.
Evidence of Accomplishments
To support the petition, NAILG highlighted the client’s impressive academic and research record, including:
- 7 peer-reviewed journal articles (1 of them first-authored).
- 27 citations to her published work, reflecting recognition by other experts.
Her research has also been cited by other scholars studying diabetes therapies, cancer prevention, and the medicinal benefits of natural compounds, underscoring its broad applicability and influence across pharmacological science.
Recognition and Expert Support
Further strengthening the case, the petition included two independent recommendation letters from experts in the field. These letters attested to her unique methodologies, her proven ability to advance pharmacological science, and the national importance of her contributions. One recommender noted:
“Her knowledge and expertise make Client a significant figurehead in advancing medicinal techniques and practices, and it is unlikely any other researcher can compare to her remarkable skill set.”
NIW Approval and Outlook
USCIS approved the petition after recognizing that the client is well-positioned to continue advancing her proposed endeavor and that waiving the job offer and labor certification requirements is in the national interest. With NAILG’s support, the petition demonstrated her consistent record of impactful research and her potential to generate new therapeutic strategies for cancer treatment. This approval enables her to continue her vital work in pharmacology, advancing drug discovery and contributing to the nation’s biomedical innovation.